Actin reorganization in CHO AA8 cells undergoing mitotic catastrophe and apoptosis induced by doxorubicin

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 655-663

  Grzanka, D ^a   Grzanka, A ^a   Izdebska, M ^a   Gackowska, L ^a   Stepien, A ^a   Marszalek, A ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Actin; Apoptosis; CHO AA8; Mitotic catastrophe

Indexed keywords

DOXORUBICIN; F ACTIN;

ACTIN FILAMENT; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL VACUOLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; GIANT CELL; MITOSIS INHIBITION; MULTINUCLEAR CELL; NONHUMAN; PLOIDY; PRIORITY JOURNAL;

ACTINS; ANIMALS; ANNEXIN A5; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; CHO CELLS; CRICETINAE; CRICETULUS; DOXORUBICIN; FLOW CYTOMETRY; IN SITU NICK-END LABELING; MICROSCOPY, IMMUNOELECTRON; MITOSIS;

EID: 77349083681     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000681     Document Type: Article

References (58)

1. Hortobágyi GN: Anthracyclines in the treatment of cancer. An overview. Drugs 54: 1-7, 1997.
2. Gewirtz DA: A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741, 1999.
3. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M and Kawanishi S: Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 76: 1439-1453, 2005.
4. Childs AC, Phaneuf SL, Dirks AJ, Phillips T and Leeuwenpburgh C: Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 62: 4592-4598, 2002.
5. Rebbaa A, Chou PM, Emran M and Mirkin BL: Doxorubicininduced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria. Cancer Chemother Pharmacol 48: 423-428, 2001.
6. Grzanka D, Domaniewski J and Grzanka A: Effect of doxorubicin on actin reorganization in Chinese hamster ovary cells. Neoplasma 52: 46-51, 2005.
7. Eom YW, Kim MA, Park SS, et al: Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24: 4765-4777, 2005.
8. Park SS, Eom YW and Choi KS: Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun 334: 1014-1021, 2005.
9. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R and Kroemer G: Cell death by mitotic catastrophe: a molecular definition. Oncogene 23: 2825-2837, 2004.
10. Malorni W and Fiorentini C: Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? FASEB J 20: 606-609, 2006.
11. Nitta M, Kobayashi O, Honda S, et al: Spindle checkpoint function is required for mitotic catastrophe induced by DNAdamaging agents. Oncogene 23: 6548-6558, 2004.
12. Skwarska A, Augustin E and Konopa J: Sequential induction of mitotic catastrophe followed by apoptosis in human leukemia MOLT4 cells by imidazoacridinone C-1311. Apoptosis 12: 2245-2257, 2007.
13. Erenpreisa J and Cragg MS: Mitotic death: a mechanism of survival? A review. Cancer Cell Int 1: 1, 2001.
14. Kroemer G, Galluzzi L, Vandenabeele P, et al: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11, 2009.
15. Thorburn A: Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13: 1-9, 2008.
16. Hightower RC and Meagher RB: The molecular evolution of actin. Genetics 114: 315-332, 1986.
17. Carlier MF and Pantaloni D: Control of actin assembly dynamics in cell motility. J Biol Chem 282: 23005-23009, 2007.
18. White SR, Williams P, Wojcik KR, Sun S, Hiemstra PS, Rabe KF and Dorscheid DR: Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 24: 282-294, 2001.
19. Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM and Landry J: SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 143: 1361-1373, 1998.
20. Levee MG, Dabrowska MI, Lelli JL Jr and Hinshaw DB: Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 271: 1981-1992, 1996.
21. Bursch W, Hochegger K, Torok L, Marian B, Ellinger A and Hermann RS: Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 113: 1189-1198, 2000.
22. Martin DN and Baehrecke EH: Caspases function in autophagic programmed cell death in Drosophila. Development 131: 275-284, 2004.
23. Croft DR, Coleman ML, Li S, Robertson D, Sullivan T, Stewart CL and Olson MF: Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J Cell Biol 168: 245-255, 2005.
24. Grzanka A, Grzanka D and Orlikowska M: Fluorescence and ultrastructural localization of actin distribution patterns in the nucleus of HL-60 and K-562 cell lines treated with cytostatic drugs. Oncol Rep 11: 765-770, 2004.
25. Amankwah KS and De Boni U: Ultrastructural localization of filamentous actin within neuronal interphase nuclei in situ. Exp Cell Res 210: 315-325, 1994.
26. Milankov K and De Boni U: Cytochemical localization of actin and myosin aggregates in interphase nuclei in situ. Exp Cell Res 209: 189-199, 1993.
27. Sasseville AM and Langelier Y: In vitro interaction of the carboxy-terminal domain of lamin A with actin. FEBS Lett 425: 485-489, 1998.
28. Bettinger BT, Gilbert DM and Amberg DC: Actin up in the nucleus. Nat Rev Mol Cell Biol 5: 410-415, 2004.
29. Pederson T and Aebi U: Nuclear actin extends, with no contraction in sight. Mol Biol Cell 16: 5055-5060, 2005.
30. Percipalle P, Jonsson A, Nashchekin D, Karlsson C, Bergman T, Guialis A and Daneholt B: Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins. Nucleic Acids Res 30: 1725-1734, 2002.
31. Gamen S, Anel A, Lasierra P, Alava MA, Martinez-Lorenzo MJ, Piñeiro A and Naval J: Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fasindependent way. FEBS Lett 417: 360-364, 1997.
32. Kotamraju S, Konorev EA, Joseph J and Kalyanaraman B: Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 275: 33585-33592, 2000.
33. Lorenzo E, Ruiz-Ruiz C, Quesada AJ, Hernández G, Rodríguez A, López-Rivas A and Redondo JM: Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J Biol Chem 277: 10883-10892, 2002.
34. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, et al: A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761-3767, 1999.
35. Rebbaa A, Zheng X, Chou PM and Mirkin BL: Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-2811, 2003.
36. Mansilla S, Priebe W and Portugal J: Transcriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53. Eur J Pharmacol 540: 34-45, 2006.
37. Johansson F, Lagerqvist A, Filippi S, Palitti F, Erixon K, Helleday T and Jenssen D: Caffeine delays replication fork progression and enhances UV-induced homologous recombination in Chinese hamster cell lines. DNA Repair 5: 1449-1458, 2006.
38. Lee JH, Lee E, Park J, Kim E, Kim J and Chung J: In vivo p53 function is indispensable for DNA damage-induced apoptotic signaling in Drosophila. FEBS Lett 550: 5-10, 2003.
39. Wang P, Yu J and Zhang L: The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 104: 4054-4059, 2007.
40. Chu K, Teele N, Dewey MW, Albright N and Dewey WC: Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell lines. Radiat Res 162: 270-286, 2004.
41. Erenpreisa J, Ivanov A, Wheatley SP, Kosmacek EA, Ianzini F, Anisimov AP and Mackey M: Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol Int 32: 1044-1056, 2008.
42. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N and Métivier D: Inhibition of macroautophagy triggers apoptosis. J Cell Sci 118: 3091-3102, 2005.
43. Kourtis N and Tavernarakis N: Autophagy and cell death in model organisms. Cell Death Differ 16: 21-30, 2009.
44. Bergmann A: Autophagy and cell death: no longer at odds. Cell 131: 1032-1034, 2007.
45. Abraham MC and Shaham S: Death without caspases, caspases without death. Trends Cell Biol 14: 184-193, 2004.
46. Kessel D: Promotion of PDT efficacy by a Bcl-2 antagonist. Photochem Photobiol 84: 809-814, 2008.
47. Suarez-Huerta N, Mosselmans R, Dumont JE and Robaye B: Actin depolymerization and polymerization are required during apoptosis in endothelial cells. J Cell Physiol 184: 239-245, 2000.
48. Grzanka A: Actin distribution patterns in HL-60 leukemia cells treated with etoposide. Acta Histochem 103: 453-464, 2001.
49. Grzanka A, Grzanka D and Orlikowska M: Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem Pharmacol 66: 1611-1617, 2003.
50. Hasinoff BB, Abram ME, Chee GL, Huebner E, Byard EH, Barnabé N and Ferrans VJ: The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells. J Pharmacol Exp Ther 295: 474-483, 2000.
51. Grzanka D, Stepien A, Grzanka A, Gackowska L, Helmin-Basa A and Szczepanski MA: Hyperthermia-induced reorganization of microtubules and microfilaments and cell killing in CHO AA8 cell line. Neoplasma 55: 409-415, 2008.
52. Stepien A, Grzanka A, Grzanka D, Andrzej Szczepanski M, Helmin-Basa A and Gackowska L: Taxol-induced polyploidy and cell death in CHO AA8 cells. Acta Histochem (In press).
53. Olave IA, Reck-Peterson SL and Crabtree GR: Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 71: 755-781, 2002.
54. McDonald D, Carrero G, Andrin C, de Vries G and Hendzel MJ: Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations. J Cell Biol 172: 541-552, 2006.
55. Pederson T: As functional nuclear actin comes into view, is it globular, filamentous, or both? J Cell Biol 180: 1061-1064, 2008.
56. Volkman LE, Talhouk SN, Oppenheimer DI and Charlton CA: Nuclear F-actin: a functional component of baculovirus-infected lepidopteran cells? J Cell Sci 103: 15-22, 1992.
57. Ye J, Zhao J, Hoffmann-Rohrer U and Grummt I: Nuclear myosin I acts in concert with polymeric actin to drive RNA polymerase I transcription. Genes Dev 22: 322-330, 2008.
58. Okorokov AL, Rubbi CP, Metcalfe S and Milner J: The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 21: 356-367, 2002.